Related Experiment Video
Updated: Jul 27, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Integrated genomics and proteomics analysis of Paenibacillus peoriae IBSD35 and insights into its antimicrobial
Ng Ngashangva1, Pulok K Mukherjee1, Chandradev Sharma1
1A National Institute of Department of Biotechnology, Institute of Bioresources and Sustainable Development (IBSD), Govt. of India, Takyelpat, Imphal, Manipur, 795001, India.
Abstract:
Antimicrobial resistance has been developing fast and incurring a loss of human life, and there is a need for new antimicrobial agents. Naturally occurring antimicrobial peptides offer the characteristics to counter AMR because the resistance development is low or no resistance. Antimicrobial peptides from Paenibacillus peoriae IBSD35 cell-free supernatant were salted out and purified using chromatography and characterized with liquid chromatography-tandem-mass spectrometry. The extract has shown a high and broad spectrum of antimicrobial activity. Combining the strain IBSD35 genome sequence with its proteomic data enabled the prediction of biosynthetic gene clusters by connecting the peptide from LC-MS/MS data to the gene that encode. Antimicrobial peptide databases offered a platform for the effective search, prediction, and design of AMPs and expanded the studies on their isolation, structure elucidation, biological evaluation, and pathway engineering. The genome-based taxonomy and comparisons have shown that P. peoriae IBSD35 is closely related to Paenibacillus peoriae FSL J3-0120. P. peoriae IBSD35 harbored endophytic trait genes and nonribosomal peptide synthases biosynthetic gene clusters. The comparative genomics revealed evolutionary insights and facilitated the discovery of novel SMs using proteomics from the extract of P. peoriae IBSD35. It will increase the potential to find novel bio-molecules to counter AMR.
Insights
New antimicrobial peptides from Paenibacillus peoriae IBSD35 show broad-spectrum activity against resistant microbes. This discovery offers potential for novel antimicrobial agents to combat antimicrobial resistance (AMR).
Area of Science:
- Microbiology
- Biochemistry
- Genomics
Background:
- Antimicrobial resistance (AMR) is a growing global health threat requiring novel therapeutic strategies.
- Naturally occurring antimicrobial peptides (AMPs) present a promising alternative due to low resistance development.
- Paenibacillus peoriae IBSD35 was investigated as a source of potent antimicrobial compounds.
Purpose of the Study:
- To isolate and characterize antimicrobial peptides from Paenibacillus peoriae IBSD35.
- To identify the biosynthetic gene clusters responsible for AMP production.
- To explore the potential of these AMPs as novel agents against AMR.
Main Methods:
- Cell-free supernatant from P. peoriae IBSD35 was processed using salting out and chromatography.
- Purified peptides were analyzed using liquid chromatography-tandem-mass spectrometry (LC-MS/MS).
- Genomic and proteomic data were integrated to predict biosynthetic gene clusters.
Main Results:
- The purified extract demonstrated high, broad-spectrum antimicrobial activity.
- LC-MS/MS identified specific peptides, which were linked to their encoding genes via genomic data.
- P. peoriae IBSD35 possesses genes for endophytic traits and nonribosomal peptide synthetases.
Conclusions:
- Paenibacillus peoriae IBSD35 is a viable source for discovering novel antimicrobial peptides.
- Integrated genomics and proteomics facilitate the identification of AMP biosynthetic pathways.
- This research enhances the potential for developing new bio-molecules to combat antimicrobial resistance.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Modern Molecular Taxonomy
Clinical Significance of Antibiotic Resistance

